查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1646736

全球蟲媒病毒檢測市場

Arbovirus Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球蟲媒病毒檢測市場規模將達到 18 億美元

2024 年全球蟲媒病毒檢測市場規模估計為 13 億美元，預計到 2030 年將達到 18 億美元，2024-2030 年分析期間的複合年成長率為 5.9%。 ELISA 測試是報告中分析的細分市場之一，預計在分析期結束時複合年成長率為 5.5%，達到 10 億美元。在分析期內，基於 RT-PCR 的測試部分預計將以 6.3% 的複合年成長率成長。

美國市場規模估計為 3.303 億美元，中國市場預期複合年成長率為 9.0%

預計2024年美國蟲媒病毒檢測市值將達3.303億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 4.19 億美元，在 2024 年至 2030 年的分析期內，複合年成長率為 9.0%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.5% 和 4.5%。在歐洲，德國的複合年成長率預計為 4.0%。

全球蟲媒病毒檢測市場-主要趨勢與促進因素摘要

為什麼蟲媒病毒檢測對現代公共衛生很重要？

蟲媒病毒（節肢動物傳播的病毒）透過被感染的節肢動物（例如蚊子和蜱蟲）叮咬傳播給人類，對全世界的公共衛生構成了重大挑戰。隨著茲卡病毒、登革熱、基孔肯雅病和西尼羅河病毒等疾病成為流行病，尤其是在熱帶和亞熱帶地區，對有效的蟲媒病毒檢測的需求從未如此強烈。早期準確檢測這些病毒對於控制疫情、指導治療和實施預防措施至關重要。蟲媒病毒檢測包括多種診斷方法，包括PCR（聚合酵素鏈鎖反應）等分子生物學技術、檢測抗體的血清學檢測以及細胞培養中的病毒分離。這些檢測的重要性在於它們能夠確認感染、區分不同的蟲媒病毒並為流行病學監測提供重要資料。由於氣候變遷、都市化和全球旅行增加等因素導致全球蟲媒病毒感染發病率增加，檢測對於減少這些疾病影響的作用在公共衛生工作中變得越來越重要。

科技進步如何增強蟲媒病毒檢測？

技術進步大大提高了蟲媒病毒檢測的能力和準確性，從而可以更快、更可靠地進行診斷並更好地管理疫情。分子診斷技術，特別是即時PCR，徹底改變了蟲媒病毒檢測方式，可以快速、高度特異性地檢測病毒 RNA（通常在數小時內完成）。這些技術使得區分密切相關的病毒成為可能，並且在多種蟲媒病毒流行的地區至關重要。此外，次世代定序儀(NGS) 已成為蟲媒病毒識別和表徵的有力工具，提供了對病毒遺傳學的詳細了解，並有助於檢測新的和正在出現的菌株。攜帶式和就地檢驗設備的創新也擴大了在偏遠和資源有限的環境中獲得蟲媒病毒診斷的機會，因為及時診斷對這些環境至關重要。這些進步，加上人工智慧和機器學習在資料分析中的整合，不僅提高了蟲媒病毒檢測的準確性和效率，也使得公共衛生應對更加積極主動。

哪些新興趨勢將影響蟲媒病毒檢測的未來？

幾個新興趨勢正在塑造蟲媒病毒檢測的未來，反映了公共衛生策略、技術創新和環境因素的更廣泛變化。一個重要的趨勢是人們越來越重視可以從單一樣本同時檢測多種病原體的多重測試。這將簡化診斷過程並為公共衛生決策提供更全面的資料，這在不同蟲媒病毒共同傳播的地區尤其重要。另一個重要趨勢是開發血清學檢測，提高其敏感性和特異性，可以更準確地檢測過去的感染並衡量人群的免疫水平。此外，數位健康平台和行動應用程式在疾病監測中的廣泛使用增強了蟲媒病毒病例的追蹤和報告，有利於即時監測疫情。此外，診斷資料與環境資料（如天氣和蚊子數量趨勢）的整合正變得越來越普遍，從而可以對蟲媒病毒的傳播進行預測建模。這些趨勢正在刺激蟲媒病毒檢測領域的創新，並確保其仍然是全球衛生安全的關鍵組成部分。

哪些因素推動了蟲媒病毒檢測市場的成長？

蟲媒病毒檢測市場的成長受到技術進步、公共衛生需求不斷發展和環境變化等多種因素的推動。首先，全球蟲媒病毒感染發生率不斷上升，特別是在受氣候變遷和都市化影響的地區，推動了對可靠且擴充性的檢測解決方案的需求。其次，分子診斷和就地檢驗技術的進步擴大了蟲媒病毒檢測的可近性和效率，使得在臨床和現場環境中能夠更快、更準確地進行診斷。第三，特別是在旅遊和旅遊業領域，人們對預防性衛生措施的認知和實施不斷提高，對預防性檢測和監測系統的需求也在增加。此外，以媒介傳播感染疾病控制為重點的全球衛生計畫不斷擴大，正在刺激對蟲媒病毒檢測基礎設施和監測的投資增加。這些因素，加上創新診斷工具的發展和數位健康技術的日益融合，正在刺激蟲媒病毒檢測市場的強勁成長，使其成為全球對抗新興感染疾病的關鍵要素。

部分

檢測類型（基於 ELISA 的檢測、基於 RT-PCR 的檢測）；最終使用者（公共衛生實驗室、醫院、診斷中心、其他最終使用者）

受訪公司範例（總合42家公司）

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP10361

Global Arbovirus Testing Market to Reach US$1.8 Billion by 2030

The global market for Arbovirus Testing estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the RT-PCR based Tests segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$330.3 Million While China is Forecast to Grow at 9.0% CAGR

The Arbovirus Testing market in the U.S. is estimated at US$330.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$419.0 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Arbovirus Testing Market - Key Trends and Drivers Summarized

Why Is Arbovirus Testing Crucial in Modern Public Health?

Arboviruses, or arthropod-borne viruses, are transmitted to humans through the bites of infected mosquitoes, ticks, and other arthropods, posing significant public health challenges worldwide. With diseases such as Zika, Dengue, Chikungunya, and West Nile Virus becoming more prevalent, especially in tropical and subtropical regions, the need for effective arbovirus testing has never been more critical. Early and accurate detection of these viruses is essential for controlling outbreaks, guiding treatment, and implementing preventive measures. Arbovirus testing encompasses a range of diagnostic methods, including molecular techniques like PCR (Polymerase Chain Reaction), serological tests to detect antibodies, and virus isolation in cell cultures. The importance of these tests lies in their ability to confirm infections, differentiate between various arboviruses, and provide critical data for epidemiological surveillance. As the global incidence of arbovirus infections rises, driven by factors such as climate change, urbanization, and increased global travel, the role of testing in mitigating the impact of these diseases is becoming increasingly central to public health efforts.

How Are Technological Advances Enhancing Arbovirus Testing?

Technological advances are significantly enhancing the capabilities and accuracy of arbovirus testing, enabling faster, more reliable diagnosis, and better outbreak management. Molecular diagnostics, particularly real-time PCR, have revolutionized arbovirus testing by offering rapid and highly specific detection of viral RNA, often within hours. These techniques allow for the differentiation of closely related viruses, which is crucial in regions where multiple arboviruses are endemic. Additionally, next-generation sequencing (NGS) is emerging as a powerful tool in the identification and characterization of arboviruses, providing detailed insights into viral genetics and aiding in the detection of novel or emerging strains. Innovations in portable and point-of-care testing devices are also expanding access to arbovirus diagnostics in remote or resource-limited settings, where timely diagnosis is critical. These advancements, coupled with the integration of AI and machine learning in data analysis, are not only improving the accuracy and efficiency of arbovirus testing but also enabling more proactive public health responses.

What Emerging Trends Are Shaping the Future of Arbovirus Testing?

Several emerging trends are shaping the future of arbovirus testing, reflecting broader changes in public health strategies, technological innovation, and environmental factors. One significant trend is the increasing emphasis on multiplex testing, which allows for the simultaneous detection of multiple pathogens from a single sample. This is particularly important in regions where co-circulation of different arboviruses is common, as it streamlines the diagnostic process and provides more comprehensive data for public health decision-making. Another important trend is the development of serological tests with improved sensitivity and specificity, which can more accurately detect past infections and measure population immunity levels. Additionally, the growing use of digital health platforms and mobile apps for disease surveillance is enhancing the tracking and reporting of arbovirus cases, facilitating real-time monitoring of outbreaks. The integration of environmental data, such as climate and mosquito population trends, with diagnostic data is also becoming more prevalent, enabling more predictive modeling of arbovirus spread. These trends are driving innovation in the field of arbovirus testing, ensuring that it remains a critical component of global health security.

What Factors Are Driving Growth in the Arbovirus Testing Market?

The growth in the arbovirus testing market is driven by several factors that align with technological advancements, evolving public health needs, and environmental changes. Firstly, the increasing global incidence of arbovirus infections, particularly in regions affected by climate change and urbanization, is propelling demand for reliable and scalable testing solutions. Secondly, advancements in molecular diagnostics and point-of-care testing technologies are expanding the accessibility and efficiency of arbovirus testing, enabling quicker and more accurate diagnosis in both clinical and field settings. Thirdly, the growing awareness and implementation of preventive health measures, particularly in travel and tourism, are driving demand for preemptive testing and surveillance systems. Additionally, the expansion of global health initiatives focused on combating vector-borne diseases is fostering increased investment in arbovirus testing infrastructure and research. These factors, combined with the ongoing development of innovative diagnostic tools and the integration of digital health technologies, are fueling robust growth in the arbovirus testing market, positioning it as a critical element in the global fight against emerging infectious diseases.

SCOPE OF STUDY:

The report analyzes the Arbovirus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (ELISA-Based Tests, RT-PCR Based Tests); End-Use (Public Health Laboratory, Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Arbovirus Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Arbovirus Infections Spurs Growth in Testing Demand
    • Advancements in Molecular Diagnostics Propel Innovation in Arbovirus Testing
    • Increasing Adoption of Multiplex Testing Strengthens Business Case for Advanced Diagnostics
    • Expansion of Point-of-Care Testing Solutions Drives Accessibility in Remote Areas
    • Growing Use of AI and Machine Learning in Data Analysis Enhances Testing Accuracy
    • Increasing Focus on Travel-Related Health Measures Expands Market Opportunities
    • Advancements in Serological Testing Drive Demand for Enhanced Immunity Monitoring
    • Here's How Portable Testing Devices Are Enhancing Response Capabilities in Epidemic Zones
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISA-based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Arbovirus Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION